Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
DXCM
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
-0.27%
$280.50-0.76
Market Cap
$37.45B
52W Range
$273.11 - $495.55
DXCM
DexCom, Inc.
+0.46%
$74.46+0.34
Market Cap
$28.73B
52W Range
$54.11 - $89.98
| Metric | ALNY | DXCM |
|---|---|---|
| Valuation | ||
| P/E Ratio | 66.81 | 31.68 |
| Forward P/E | 37.91 | 28.58 |
| P/B Ratio | 36.15 | 9.87 |
| P/S Ratio | 9.07 | 6.06 |
| P/FCF Ratio | 60.62 | 20.41 |
| PEG Ratio | - | 0.67 |
| EV/EBITDA | 47.64 | 22.78 |
| Profitability | ||
| Gross Margin | 80.9% | 61.8% |
| Operating Margin | 17.5% | 21.4% |
| Net Margin | 13.5% | 19.3% |
| ROE | 53.7% | 31.5% |
| ROA | 11.3% | 14.0% |
| ROIC | 13.7% | 16.6% |
| Financial Health | ||
| Current Ratio | 2.76 | 1.88 |
| Quick Ratio | 2.71 | 1.59 |
| Debt/Equity | 1.62 | 0.51 |
| Interest Coverage | 1.99 | 49.83 |
| Dividends | ||
| Dividend Yield | - | - |
| Payout Ratio | - | - |
| Consecutive Div Years | 0 | 0 |